J3055

HCPCS

Inj talquetamab-tgvs 0.25 mg

Official HCPCS Level II long descriptor

Injection, talquetamab-tgvs, 0.25 mg

HCPCS Level II code J3055 is maintained by CMS and is active in the current quarterly release.

Short descriptor

Inj talquetamab-tgvs 0.25 mg

Added to HCPCS: 2024-04-01

Nearby codes in J3

J3000Streptomycin injection
J3010Fentanyl citrate injection
J3030Sumatriptan succinate / 6 mg
J3031Inj., fremanezumab-vfrm 1 mg
J3032Inj. eptinezumab-jjmr 1 mg
J3060Inj, taliglucerase alfa 10 u
J3070Pentazocine injection
J3090Inj tedizolid phosphate
J3095Telavancin injection
J3101Tenecteplase injection
J3105Terbutaline sulfate inj
J3110Teriparatide injection
J3111Inj. romosozumab-aqqg 1 mg

Where this code sits

HCPCS Level II J3 codes

Krasyn AI Coder

Get code suggestions automatically as you type notes. Free for 50 analyses.

Install for Chrome — free

Source

HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.